ChemoCentryx, Inc. (CCXI) Friday reported a wider loss for the second quarter, due mainly to lower margins.
Net loss for the quarter widened to $10.9 million or $0.30 per share from $7.9 million or $1.90 per share in the same quarter last year.
Analysts polled by Thomson Reuters expected the company to earn $0.21 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues totaled $1.1 million, down from $1.2 million last year.
Operating expenses increased to $12.2 million from $9.2 million last year.
For comments and feedback: editorial@rttnews.com